The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 13, 2015

Filed:

Apr. 06, 2011
Applicants:

Shoji Natsugoe, Kagoshima, JP;

Yasuto Uchikado, Kagoshima, JP;

Teruto Hashiguchi, Kagoshima, JP;

Hiroyuki Shinchi, Kagoshima, JP;

Kosei Maemura, Kagoshima, JP;

Yuko Mataki, Kagoshima, JP;

Norichika Moriwaki, Tokyo, JP;

Masaru Sekijima, Tokyo, JP;

Hideyuki Shimaoka, Tokyo, JP;

Midori Abe, Tokyo, JP;

Masao Fukushima, Tokyo, JP;

Kota Igarashi, Tokyo, JP;

Hiroki Abe, Tokyo, JP;

Taichi Aihara, Tokyo, JP;

Inventors:

Shoji Natsugoe, Kagoshima, JP;

Yasuto Uchikado, Kagoshima, JP;

Teruto Hashiguchi, Kagoshima, JP;

Hiroyuki Shinchi, Kagoshima, JP;

Kosei Maemura, Kagoshima, JP;

Yuko Mataki, Kagoshima, JP;

Norichika Moriwaki, Tokyo, JP;

Masaru Sekijima, Tokyo, JP;

Hideyuki Shimaoka, Tokyo, JP;

Midori Abe, Tokyo, JP;

Masao Fukushima, Tokyo, JP;

Kota Igarashi, Tokyo, JP;

Hiroki Abe, Tokyo, JP;

Taichi Aihara, Tokyo, JP;

Assignees:

Kagoshima University, Kagoshima-shi, JP;

Sumitomo Bakelite Co., Ltd., Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/66 (2006.01); G01N 33/48 (2006.01); C12Q 1/54 (2006.01); C12Q 1/00 (2006.01); G01N 33/50 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
G01N 33/50 (2013.01); G01N 33/57446 (2013.01); G01N 33/66 (2013.01);
Abstract

As a result of collecting blood from pancreatic cancer patients, esophageal cancer patients, and stomach cancer patients, and conducting mass spectrometry on N-linked sugar chains in the plasmas, sugar chains whose abundances are significantly different from those of healthy subjects have been successfully identified from the blood samples of the cancer patients.


Find Patent Forward Citations

Loading…